Transcutaneous Auricular Vagus Nerve Stimulation in Upper Extremity Lymphedema

Launched by SEDA SAKA · Sep 29, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new method called transcutaneous auricular vagus nerve stimulation, which could help improve the quality of life for people with lymphedema in their arms. Lymphedema is a condition where fluid builds up in the tissues, causing swelling and discomfort. This trial aims to see if stimulating the vagus nerve (a nerve that helps control many body functions) alongside standard treatments can enhance grip strength and hand function in patients.

To participate, individuals must be between 18 and 65 years old and have been diagnosed with secondary lymphedema at least three months after surgery. They must also have moderate to severe lymphedema (stages 2 or 3). Participants will be randomly assigned to one of three groups: one group will receive standard treatment, another will receive standard treatment plus a fake stimulation, and the last group will receive both standard treatment and the actual nerve stimulation. This study will take place at Gaziosmanpaşa Physical Therapy Rehabilitation Training and Research Hospital, and all data will be carefully analyzed to determine the effects of the treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Between the ages of 18-65
• • Diagnosed with secondary lymphedema disease by the physician
• • Minimum of three months after surgery
• • Stage 2 and 3 patients
• • Native speaker Turkish
• • Individuals who agreed to participate in the study
• Exclusion Criteria:
• • Individuals with any neurological or orthopedic problems in the upper extremity
• • Individuals undergoing upper extremity surgery
• • Presence of cardiac edema
• • Presence of arterial disease
• • Presence of acute venous disease
• • Those with sensory impairment
• • Those with cardiac rhythm disorders
• • Individuals with cooperation problems